Mark Davies

Chairman at NEUROTECH INTERNATIONAL LIMITED

Finance

Health Technology

Consumer Services

Profile

Mark Hamlin Davies was the founder of Cygnet Capital Pty Ltd. (Investment Management), founded in 2003, where the title held was General Manager.
Mr. Davies is also the founder of Cygnet Capital Pty Ltd.,1861 Capital Pty Ltd...
Mr. Davies is Executive Chairman at Neurotech International Ltd. since 2019.
Former jobs include Non-Executive Chairman at Exopharm Ltd. and Non-Executive Chairman at Entropy Neurodynamics Ltd. Education includes undergraduate studies at The University of Western Australia.

Mark Davies active positions

Companies	Position	Start
NEUROTECH INTERNATIONAL LIMITED	Chairman	16/08/2022
1861 Capital Pty Ltd. 1861 Capital Pty Ltd. Financial ConglomeratesFinance Provides investment services	Founder	-

All active positions of Mark Davies

Former positions of Mark Davies

Companies	Position	End
Cygnet Capital Pty Ltd. (Investment Management) Cygnet Capital Pty Ltd. (Investment Management) Investment ManagersFinance Cygnet Capital-IM invests in emerging companies alongside their investment partners.	Founder	-
EXOPHARM	Chairman	-
Cygnet Capital Pty Ltd. Cygnet Capital Pty Ltd. Investment Banks/BrokersFinance Provides brokerage services	Founder	-

See the detail of Mark Davies's experience

Training of Mark Davies

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Davies's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Cygnet Capital Pty Ltd. Cygnet Capital Pty Ltd. Investment Banks/BrokersFinance Provides brokerage services	Finance
The University of Western Australia The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cygnet Capital Pty Ltd. (Investment Management) Cygnet Capital Pty Ltd. (Investment Management) Investment ManagersFinance Cygnet Capital-IM invests in emerging companies alongside their investment partners.	Finance
Neurotech International Ltd. Neurotech International Ltd. Medical SpecialtiesHealth Technology Designs, manufactures and markets neurotechnology devices	Health Technology
1861 Capital Pty Ltd. 1861 Capital Pty Ltd. Financial ConglomeratesFinance Provides investment services	Finance
Exopharm Ltd. Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent	Health Technology